🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
This is a multicenter Phase 1b study evaluating the safety, tolerability, a...
Status
Completed
Location
City of Hope
Start Date
2021-07-29
Trial ID
NCT05075603
Treatments Being Tested
The goal of this clinical study is to learn more about the study drug, axic...
Status
Completed
Location
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Start Date
2022-08-09
Trial ID
NCT05459571
Treatments Being Tested
The goal of this clinical study is to learn more about the long-term safety...
Status
Enrolling By Invitation
Location
Banner MD Anderson Cancer Center
Start Date
2021-12-15
Trial ID
NCT05041309
The primary objective of this study is to estimate the efficacy of axicabta...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2019-11-05
Trial ID
NCT04002401
Treatments Being Tested
The primary objective of this study is to estimate the efficacy of axicabta...
Status
Completed
Location
Banner Health MD Anderson Cancer Center
Start Date
2019-01-29
Trial ID
NCT03761056
Treatments Being Tested
This was a Retrospective cohort study based on the PMSI data source...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-12-09
Trial ID
NCT05349201
A multicenter, open-label expanded access protocol for the treatment of sub...
Status
Approved For Marketing
Location
City of Hope
Start Date
TBD
Trial ID
NCT03153462
Treatments Being Tested
This phase I trial evaluates the side effects and usefulness of axicabtagen...
Status
Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2025-02-13
Trial ID
NCT05077527
Treatments Being Tested
Diffuse large B-cell lymphoma is the most commonly occurring subtype of non...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2026-03-12
Trial ID
NCT07052305
Treatments Being Tested